Indication for oral 1,25-dihydroxyvitamin D3 pulse therapy in patients with renal osteodystrophy at hemodialysis induction. 1994

T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai

UI MeSH Term Description Entries
D008297 Male Males
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
January 1991, Nephron,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
May 2000, Clinical nephrology,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
June 1979, The Journal of pediatrics,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
January 1994, Nephron,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
January 1980, Contributions to nephrology,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
January 1982, Metabolic bone disease & related research,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
January 1995, Mineral and electrolyte metabolism,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
January 1980, Contributions to nephrology,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
October 2006, Clinical nephrology,
T Hyodo, and K Kumano, and T Mori, and H Shio, and Y Yoshino, and T Sakai
July 1992, Nihon Jinzo Gakkai shi,
Copied contents to your clipboard!